Purinergic signaling was first recognized in the guinea pig (Cavia porcellus) taenia coli, where relaxation of smooth muscle by nerve-released ATP may involve the activation of P2Y 1 and P2Y 11 receptors, and where transcripts for both genes have been found. A partial sequence for P2Y 11 protein was identified; the full-length P2Y 1 sequence has already been described. P2Y 1 and P2Y 11 proteins were localized by immunohistochemistry in smooth muscle cells. P2X 2 and P2X 3 proteins were also localized in motoneurons of the myenteric plexus. ␣␤-Methylene-ATP (␣␤meATP) and dibenzoyl-ATP (BzATP) evoked fast relaxations in the taenia, and they were inhibited by the P2Y 1 receptor antagonist 2Ј-deoxy-N 6 -methyladenosine 3Ј,5Ј-bisphosphate (MRS2179). However, ␣␤meATP and BzATP may stimulate neuronal P2X receptors to release ATP, which then acts on P2Y 1 receptors. In accordance, fast relaxations evoked by ␣␤meATP and BzATP were inhibited by the P2X 3 and P2X 2/3 receptor antagonist 5-({[3-phenoxybenzyl][(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] amino} carbonyl)-1,2,4-benzene-tricarboxylic acid (A317491). When P2Y 1 , P2X 3 , and P2X 2/3 receptors were blocked and adenosine was removed enzymatically, ␣␤meATP and BzATP evoked slow relaxations that were inhibited by Reactive Red. Fast and slow relaxations involve small and large conductance calcium-activated potassium channels; the latter are dependent on intracellular cyclic AMP levels, which altered the duration and amplitude of relaxations. ␣␤meATP and BzATP were confirmed as agonists, and Reactive Red as an antagonist, of human P2Y 11 receptors. In summary, G q -coupled P2Y 1 receptors are involved mainly in fast relaxations, whereas G qand G s -coupled P2Y 11 receptors are involved in both fast and slow relaxations. These P2Y receptor subtypes, plus neuronal P2X receptors, may explain the phenomenon of parasympathetic inhibition first described by Langley (1898).
5- ({[3-phenoxybenzyl] [(1S)-1,2,3,4-tetrahydro-1-naphthalenyl] amino} carbonyl)-1,2,4-benzene-tricarboxylic acid (A317491). When P2Y 1 , P2X 3 , and P2X 2/3 receptors were blocked and adenosine was removed enzymatically, ␣␤meATP and BzATP evoked slow relaxations that were inhibited by Reactive Red. Fast and slow relaxations involve small and large conductance calcium-activated potassium channels; the latter are dependent on intracellular cyclic AMP levels, which altered the duration and amplitude of relaxations. ␣␤meATP and BzATP were confirmed as agonists, and Reactive Red as an antagonist, of human P2Y 11 receptors. In summary, G q -coupled P2Y 1 receptors are involved mainly in fast relaxations, whereas G qand G s -coupled P2Y 11 receptors are involved in both fast and slow relaxations. These P2Y receptor subtypes, plus neuronal P2X receptors, may explain the phenomenon of parasympathetic inhibition first described by Langley (1898) .
Parasympathetic inhibition was a term first used to describe the relaxation of smooth muscle tone in response to electrical stimulation of the parasympathetic vagal and pelvic nerves (Langley, 1898) . Such relaxations were also described as nonadrenergic, noncholinergic inhibition, because evoked responses were resistant to drugs that interrupt cholinergic and adrenergic transmission (Burnstock et al., 1966) . Parasympathetic inhibition of the gut is mainly brought about by the rapid hyperpolarization of the membrane potential of smooth muscle cells (SMCs), by an electrical event called the inhibitory junction potential (IJP). This electrogenic relaxation requires the activation of several types of calcium (Ca 2ϩ )-activated potassium channels (SK Ca , BK Ca , and, occasionally, intermediate conductance Ca 2ϩ -activated potassium channels) present in innervated SMCs (Carl et al., 1995; Vogalis and Goyal, 1997; Hata et al., 2000) .
For the gastrointestinal tract, either ATP, nitric oxide (NO), vasoactive intestinal peptide (VIP), and/or the structurally related pituitary adenylyl cyclase-activating peptide (PACAP), or an admix of all four, is thought to mediate parasympathetic/ nonadrenergic, noncholinergic inhibition of gut SMCs (Lecci et al., 2002) . Of these autonomic neurotransmitters, ATP alone directly activates membrane surface receptors (P2Y receptors), which couple strongly to the G q/11 /phospholipase C␤ inositol 1,4,5-triphosphate pathway (King et al., 1998) and rapidly mobilize intracellular calcium ions (Ca i 2ϩ ) to open SK Ca , BK Ca , and intermediate conductance Ca -activated potassium channels (Lecci et al., 2002) . In contrast, nitrergic (NO) and peptidergic (VIP/PACAP) transmission involves the generation of cGMP and cAMP followed by protein kinase G-and protein kinase A-based downstream phosphorylation of potassium ion channels, including TREK-1 and BK Ca channels (Koh et al., 2001; Lecci et al., 2002) .
It has been proposed that two relaxant P2Y receptors are activated by ATP in gut SMCs (Bü ltmann et al., 1996; Lecci et al., 2002) . Eight mammalian P2Y subtypes (namely, P2Y 1,2,4,6,11,12,13,14 ) have been cloned, and of these subtypes, only P2Y 1,2,4,6,11 can couple efficiently to the G q/11 /phospholipase C␤ inositol 1,4,5-triphosphate pathway (Abbracchio et al., 2006) . P2Y 2 , P2Y 4 , and P2Y 6 are activated by either UTP or UDP, which are poor relaxants of SMCs; in accordance, these P2Y receptors are usually excluded from consideration (Ralevic and Burnstock, 1998) . The remaining P2Y 1 and P2Y 11 receptors are activated fully by ATP; as a result, they can rapidly mobilize Ca i 2ϩ . Although sharing these common attributes, P2Y 1 and P2Y 11 receptor subtypes also differ in a number of their signaling and pharmacological properties. For example, human P2Y 1 receptors couple exclusively to G q/11 protein (Abbracchio et al., 2006) , they are antagonized by dibenzoyl-ATP (BzATP) (Vigne et al., 1999) , and they are not activated by ␣,␤-methylene-ATP (␣␤meATP) (King et al., 1998) . By contrast, human P2Y 11 receptors can couple both to G s and G q/11 proteins (Abbracchio et al., 2006) , and they are activated fully by either BzATP or ␣␤meATP (van der Weyden et al., 2000a,b; Abbracchio et al., 2006) .
We have investigated how parasympathetic inhibition is mediated by ATP, and we focused on the involvement of P2Y 1 and P2Y 11 receptors in SMC relaxation. We have used the guinea pig (Cavia porcellus) taenia coli as a test model, because purinergic transmission was first established here (Burnstock et al., 1970) . We have also used BzATP, ␣␤meATP, and some recently developed selective P2 receptor antagonists to investigate the relative contribution made by P2Y 1 and P2Y 11 receptors in the relaxation of the taenia.
Materials and Methods
Receptor Localization: Immunohistochemistry. The distribution of ATP receptor (P2X and P2Y) subtypes in guinea pig gastrointestinal tissues was determined by immunohistochemistry using the method of Poole et al. (2002) , with modifications; namely, tissue sections were incubated postfixation in sodium citrate (10 mM, pH 6.0, at 80°C for 10 min) to allow antigen retrieval. P2X 2 and P2X 3 antibodies (Millipore Bioscience Research Reagents, Temecula, CA) were used at a dilution of 1:400. Smooth muscle cells in the guinea pig taenia coli were dispersed using the method of Albert and Large (2001) . P2Y 1 and P2Y 11 antibodies (Abcam plc, Cambridge, UK) were also used at a dilution of 1:400.
Reverse Transcription-Polymerase Chain Reaction. Total RNA was isolated from guinea pig taenia using TRIzol Reagent (Invitrogen, Paisley, UK). Forward and reverse primers for P2Y 1 (AY048684) were nucleotides 639 to 662 (5Ј-AAAACCATCACCTGC-TATGACACC-3Ј) and 817 to 797 (5Ј-TTCCTCCTCAAAGGCGAG-TTG-3Ј), respectively. Forward and reverse primers for P2Y 11 were 5Ј-CGGCTGTGGTCTTCTCGGC-3Ј and 5Ј-AGGCTGATGCAGGT-GAGGAA-3Ј, respectively. Polymerase chain reaction (PCR) was performed with the AccuPrime GC-rich DNA Polymerase kit (Invitrogen), using either 1/10 of the reverse transcription reaction (first amplification reaction) or 1/25 of the first PCR amplification (second amplification reaction) in a total volume of 25 l containing 5 pmol of each of the forward and reverse primers, 1ϫ reaction buffer A (for P2Y 11 ) or B (for P2Y 1 ), and 1 l of DNA polymerase. Cycling conditions for the first round of amplification were 1 min at 94°C, followed by 30 cycles of (15 s at 94°C, 20 s at 63°C, and 15 s at 68°C), with a final 3 min at 68°C. Cycling conditions for the second round of amplification were as follows: 3 min at 94°C followed by 30 cycles of 15 s at 94°C, 15 s at either 63°C (P2Y 1 ) or 70°C (P2Y 11 ), and 15 s at 72°C followed by 3 min at 72°C. The amplified fragments were purified and cloned for DNA sequence analysis. In total, nine independent P2Y 1 fragment clones and 10 independent P2Y 11 fragment clones were sequenced.
Organ Bath Pharmacology. All animals were housed and cared for in accordance with Home Office (UK) regulations. Guinea pigs (450 -700 g) were killed by an approved schedule 1 method (cervical dislocation), after which the taenia coli were removed surgically. Strips of guinea pig taenia coli approximately 15 mm in length were suspended vertically in a 5-ml organ bath, with the upper end of the strip attached to an isometric force transducer (FT03; Gould Instrument Systems Inc., Cleveland, OH). The bathing solution contained 133 mM NaCl, 4.7 mM KCl, 1.4 mM NaH 2 PO 4 , 16.4 mM NaHCO 3 , 0.6 mM MgSO 4 , 7.7 mM D-glucose, and 2.5 mM CaCl 2 , bubbled continuously with 95% O 2 , 5% CO 2 . Muscle strips were allowed to equilibrate for approximately 1 h at 37°C before being placed under 1-g resting tension. Tension recordings were stored using a PC and analyzed offline using AcqKnowledge III (BIOPAC Systems, Inc., Goleta, CA). Pharmacological data are expressed as the mean EC 50 value. Nonlinear regression and Schild analyses were performed using Prism 3.0 (GraphPad Software Inc., San Diego, CA). Significant differences (p Ͻ 0.05) between data points were determined by Student's t test using Instat 2.05A (GraphPad Software Inc.).
Signal Transduction Assays: Heterologous Expression. Human P2Y 11 cDNA was transfected into human astrocytoma 1321N1 cells using Lipofectamine LF2000 (Invitrogen) and stably selected using 400 g ⅐ ml Ϫ1 Geneticin (G-418; Invitrogen). Cells were grown in Phenol Red-free Dulbecco's modified Eagle's medium supplemented with 2 mM L-glutamine and 10% fetal bovine serum. Changes in the levels of intracellular calcium were assayed using a fluorometric imaging plate reader (FLIPR; Molecular Devices, Sunnyvale, CA). Cells were plated in poly-D-lysine-coated, black-walled, clear-bottomed 96-well tissue culture plates at a density of 10 5 cells per well, and cells were allowed to grow to confluence (approximately 48 h). Cells were loaded using the Calcium Plus Assay dye (Molecular Devices) for 30 min at 37°C without washing, before they were assayed. Cell fluorescence was monitored every second for 10 s before agonist addition. Agonists were added as 10ϫ stocks, and fluorescence was monitored for a further 170 s. Antagonists, where included, were preincubated for a 30-min period before agonist addition. Concentration-response curves were generated using peak height (maximal response Ϫ minimal response) values. Nonlinear regression and Schild analysis were performed using Prism 3.0 (GraphPad Software Inc.).
Results
Molecular Identification of P2Y 1 and P2Y 11 Receptor Transcripts. Whole genome shotgun C. porcellus sequences, submitted to the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov) trace archive database (version 4.0), were queried using human and canine P2Y 11 receptor sequences. Four overlapping guinea pig P2Y 11 genomic clones were identified (trace identifier nos. 816740877, 775645507, 835465461, and 816939529), and they were used to design gene-specific primers. Primers for P2Y 1 were derived from the published sequence of guinea pig P2Y 1 (AY048684).
Single fragments of the expected size for both P2Y 1 (179 base pairs) and P2Y 11 (187 base pairs) were observed after PCR amplification. No amplified products were detected in the control reactions (Fig. 1A) , indicating that single P2Y 1 and P2Y 11 products were derived from reverse transcribed taenia coli mRNA and not from contaminating genomic DNA. The identity of the 179-base pair P2Y 1 and 187-base pair P2Y 11 amplification products was confirmed by DNA sequencing. The predicted amino acid sequence of the P2Y 11 amplification product is 81 and 78% identical to the same region (amino acid residues 64 -124) of the human and canine P2Y 11 receptor proteins, respectively (Fig. 1B) . This is the first reported P2Y 11 sequence from a rodent-like (lagomorph) species. The nucleotide sequences of the guinea pig, human, and canine P2Y 11 receptors are highly conserved at 71.7, 66.8, and 64.7%, respectively. The full nucleotide sequence for guinea pig P2Y 1 has already been reported (AY048684).
Cellular Localization of P2Y 1 and P2Y 11 Receptor Proteins. Enzymatically dispersed SMCs from the guinea pig taenia coli were stained with the nuclear dye 4Ј,6-diamidino-2-phenylindole (DAPI), and then they were stained again for P2Y 1 and P2Y 11 immunoreactivity (Fig. 2 ). SMCs were spindle shaped and measured 300 to 400 m in length and 10 to 15 m in diameter, and the DAPI-stained nucleus was centrally located (Fig. 2, top) . Immunopositive staining for either P2Y 1 or P2Y 11 protein was seen in single SMCs seeded on separate coverslips (Fig. 2, bottom) . No significant immunolabeling occurred where SMCs were processed without the primary P2Y antisera.
Localization of P2X Subunit Proteins in Myenteric Motoneurons. Spread preparations of the guinea pig taenia coli were used to isolate small myenteric ganglia lying in spaces between stretched smooth muscle bundles. In a series of paraformaldehyde-fixed spread preparations, neurons were observed in interbundle myenteric ganglia, and, here, positive P2X 3 immunostaining was also identified (Fig. 3) . In complementary studies, the myenteric plexus was further processed for both P2X 3 and P2X 2 immunoreactivity in thin sections of the full wall of the guinea pig caecum where the taenia muscle bands are located. Positive staining was observed only when antigen retrieval methods were applied to fixed tissue sections (see Materials and Methods). Thereafter, a majority of ganglia showed colocalization of P2X 3 and P2X 2 immunostaining in adjacent tissue sections (Fig. 3) .
Nucleotide-Evoked Relaxations of Taenia Coli. Muscle strips from the guinea pig taenia coli were stimulated with 30 nM carbachol, which produced approximately 80% of maximal tone and established a state of persistent contraction (Fig. 4A) . ATP, BzATP, and ␣␤meATP caused brief relaxations of increasing size, in a concentration-dependent manner, in carbacholprecontracted taenia muscle strips (Fig. 4, A and B) . Analysis of relaxant responses showed that BzATP and ␣␤meATP were equipotent, with mean EC 50 values of 2.96 and 2.00 M, respectively (see control data in Table 1 ). Their C/R curves were steep (n H ϳ 2), and they rose from minimum to maximum over a single log 10 unit of concentration. Some form of co-operativity may have caused this acute sensitivity to these relaxants, and potential molecular targets for such co-operativity include the Fig. 2 . Enzymatically dispersed SMCs from guinea pig taenia coli were processed for DAPI nuclear staining and for P2Y 1 and P2Y 11 immunostaining thereafter. Isolated SMCs were viewed under phase-contrast microscopy to help observe cell shape (phase ϩ DAPI; top). By fluorescence microscopy, the presence of P2Y 1 and P2Y 11 immunoreactivity (P2Y 1 -ir and P2Y 11 -ir; lower panels) was confirmed in the same pair of cells (top). Scale bar, 50 m. 1 and 4) . The fragment sizes of molecular weight markers (lane 3) are indicated to the right of the panel in base pairs. Below A, the predicted translation product of the amplified guinea pig P2Y 11 fragment (gpP2Y 11 ) is aligned with the corresponding region of the human (hP2Y 11 ) and canine P2Y 11 (dP2Y 11 ) receptor proteins. B, asterisks, under the alignments, indicate residues conserved in all three P2Y 11 receptor proteins.
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Inhibition and Potentiation of Nucleotide-Evoked Relaxations. Two antagonists were used to change the tissue sensitivity to the above-mentioned three relaxant nucleotides (see antagonist data in Table 1 ). The first was MRS2179 (100 M), which blocks P2Y 1 receptors, and the second was A317491 (100 M), which blocks P2X 3 and P2X 2/3 receptors. The potency of ATP, BzATP, and ␣␤meATP was significantly reduced by the P2Y 1 receptor antagonist MRS2179, although ATP alone can activate P2Y 1 receptors. Instead, BzATP and ␣␤meATP may act through P2X receptors on inhibitory motor nerves to release ATP. This possibility was supported in experiments showing that the potency of ATP, BzATP, and ␣␤meATP was further reduced by blocking P2X 3 receptors and P2X 2/3 receptors with A317491 in the presence of MRS 2179 (see antagonist data in Table 1 ).
The relaxant potency of ATP, BzATP, and ␣␤meATP was augmented by adding adenosine deaminase (ADA) at a final concentration of 2 U ml Ϫ1 to the organ baths, in the added presence of MRS2179 and A317491 (see deaminase data in Table 1 ). ADA rapidly removes adenosine in the bathing solution, and it may prevent the activation of inhibitory adenosine receptors present on nerve and muscle. With ADA present, both ATP and BzATP were found to be equipotent (mean EC 50 values of 5.7 and 6.6 M, respectively), whereas ␣␤meATP was 10-fold less potent than either (mean EC 50 of 66.6 M).
In control experiments, isoprenaline (0.01-100 M) was used to see whether MRS2179, A317491, and ADA exerted any nonspecific effects on smooth muscle relaxations. Fast-to-Slow Conversion of Nucleotide-Evoked Relaxations. The combination of MRS2179 and A317491 (with, or without, ADA present) led to a second phenomenon-a conversion of fast relaxations to slow relaxations (Fig. 5A , i-iii). This was true for all three nucleotides tested (Fig. 5B) and particularly for the nonhydrolyzable ␣␤meATP (Fig. 5A) . Measuring the time to recover 50% of the original muscle tone from the onset of relaxations (T 50 value), relaxations evoked by ␣␤meATP lasted for 38 Ϯ 2 s (mean Ϯ S.E.M.; n ϭ 8) in the absence of antagonists, and, in their presence, they persisted for more than 10 min (600 s), after which the nucleotide was removed by washout to prevent P2 receptor desensitization. Reactive Red (100 M) antagonized the slow relaxations evoked by BzATP in a competitive manner, with a pK B value of 4.86 Ϯ 0.14 ( Fig. 5C) .
Conversion from fast-to-slow relaxations may depend on intracellular cAMP. Forskolin, a stimulant of adenylate cyclase, and of itself a relaxant of taenia coli (Fig. 6A) , was used at a threshold concentration (0.1 M) and thereafter increased the duration and size of submaximal responses to ␣␤meATP (Fig. 6B) . The phosphodiesterase inhibitor Ro-20-1724 (20 M) also increased the duration and size of submaximal responses to ␣␤meATP (Fig. 6C) . In contrast, the adenylate cyclase inhibitor 9-cyclopentyladenine (30 M) reduced the duration of slow relaxations (Fig. 6D) . These findings fit comfortably with the notion that P2Y 11 receptors, coupling to G q/11 and G s proteins in SMCs, increase both intracellular Ca 2ϩ and cAMP levels to, respectively, initiate and regulate parasympathetic inhibition. K ؉ Channel Blockade of Fast and Slow Relaxations. SK and BK channel blockers were tested against fast and slow relaxations of the taenia. 1,1Ј-(1,10-Cecanediyl)bis(4-amino-2-methylquinolinium) dichloride (dequalinium; 20 M) is a nonpeptide SK Ca blocker, and it failed to alter the Fig. 3 . Intrinsic motoneurons of the myenteric plexus showed P2X 3 -ir in a spread preparation of the taenia (left). In addition, consecutive sections (10 m in thickness) of the external smooth muscle layers of the guinea pig caecum showed colocalization of peroxidase-labeled P2X 3 -and P2X 2 -immunoreactivity in a series of myenteric ganglia (right, arrows). The longitudinal layer (taenia) was sectioned transversely and lay in the top half of micrographs (right). Scale bars, 10 and 100 m. Fig. 4 . Nucleotides (ATP, BzATP, and ␣␤meATP; at their maximal concentration) briefly relaxed the taenia precontracted with carbachol (Carb; 30 nM) (A). Muscle tone was reduced in a concentration-dependent manner by ATP, BzATP, and ␣␤meATP (B); data are expressed as mean Ϯ S.E.M. (n ϭ 4). Concentration/response curves for BzATP and ␣␤meATP were steep and monophasic; the curve for ATP was shallow and biphasic. Potency indices and Hill coefficients are given in Table 1. amplitude (Fig. 7A ), yet it prolonged the duration (Fig. 7B) , of fast relaxations evoked by ␣␤meATP (10 M). Iberiotoxin (0.1 M) is a peptide BK Ca blocker, and it failed to alter the amplitude (Fig. 7A ), but it shortened the duration (Fig. 7B) , of slow relaxations to BzATP (30 M). When used together, dequalinium and iberiotoxin (20 and 0.1 M) significantly reduced the size (Fig. 7A) and duration of slow relaxations, and these actions were mimicked by tetraethylammonium chloride salt (0.6 M) (Fig. 7A, inset) .
Human P2Y 11 Receptor Expressed in 1321N1 Cells. Human P2Y 11 cDNA (AF030335) was transfected into human astrocytoma 1321N1 cells maintained in Phenol Redfree Dulbecco's modified Eagle's medium. Changes in levels of intracellular calcium were assayed using a FLIPR (Molecular Devices) in cells loaded with Calcium Plus Assay dye. ATP, BzATP, and ␣␤meATP transiently elevated calcium levels in a concentration-dependent manner in transfected human astrocytoma 1321N1 cells (Fig. 8, A and B) , whereas nontransfected 1321N1 cells failed to respond. For Ca 2ϩ assays, the EC 50 values for ATP, BzATP, and ␣␤meATP agonist potency were 3.31, 1.70, and 7.24 M, respectively. These nucleotides also increased cAMP production in a concentration-dependent manner in transfected 1321N1 cells (data not shown).
A range of compounds, including suramin, MRS2179, Phenol Red, PPADS, and Reactive Red, were screened for antagonism of human P2Y 11 receptors. Suramin and Reactive Red each blocked P2Y 11 in aconcentration-dependent manner, 
Fig. 5.
Recovery from relaxations was considerably faster in taenia muscle strips studied under control conditions (A, i) than in the presence of the P2 antagonists MRS2179 (100 M) and A317491 (100 M) and enzyme ADA (2 U ml Ϫ1 ) (A, ii and iii). A slow recovery rate was observed for all nucleotides under test conditions (antagonists ϩ ADA; B), and slow relaxations evoked by BzATP (C) were antagonized competitively by Reactive Red (pK B ϭ 4.86 Ϯ 0.14; n ϭ 4).
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jpet.aspetjournals.org with IC 50 values of 16.6 and 72.4 M, respectively (Fig. 8, C  and D) . Reactive Red was shown to be a competitive antagonist at human P2Y 11 receptors (pK B of 4.76 Ϯ 0.04). It is noteworthy that MRS2179, PPADS, and Phenol Red did not antagonize human P2Y 11 receptors.
Discussion
Our experiments show that SMCs in the guinea pig taenia possess P2Y 1 and P2Y 11 receptors that mediate fast and slow purinergic relaxations. In fact, earlier work had already pointed to two unidentified P2Y receptors in this tissue (Dudeck et al., 1995; Bü ltmann et al., 1996; Lecci et al., 2002) . Historically, the first P2Y subtype was known to be activated by ATP, 2-methylthio-ATP, and adenosine-5Ј-O-(3-thio)triphosphate (Dudeck et al., 1995) and blocked by suramin, Reactive Blue 2, and isoPPADS (Bü ltmann et al., 1996) , which mirrors the pharmacological profile of P2Y 1 receptors (King et al., 1998) . ATP and the P2Y 1 agonist 2-methylthio-ATP activate SK-channels in dispersed SMCs of the taenia, and this action is antagonized by the P2Y 1 antagonist PPADS (Kong et al., 2000) . P2Y 1 receptors acting via SK-channels were shown to mediate fast hyperpolarization (IJPs) in SMCs of the guinea pig ileum (Wang et al., 2007) and human colon (Gallego et al., 2006) . However, we now report that P2Y 11 receptors represent the second, unidentified P2Y subtype in the taenia. This second P2Y subtype was activated by ␣␤meATP and other methylene phosphonates, and it was inhibited by suramin and Reactive Red (Dudeck et al., 1995; Bü ltmann et al., 1996) . Of the now known recombinant P2Y subtypes, we find that human P2Y 11 receptors are uniquely activated by ␣␤meATP and inhibited by suramin and Reactive Red.
In the present study, we found both P2Y 1 and P2Y 11 transcripts in the taenia and immunopositive P2Y 1 and P2Y 11 proteins in dispersed smooth muscle cells. We found that the selective P2Y 1 antagonist MRS2179 potently inhibited ATPmediated fast relaxations in the taenia. This compound does not block the tetrodotoxin-resistant relaxations produced by the neuropeptides VIP and PACAP or by the NO donor sodium nitroprusside in human colon (Gallego et al., 2006) . In addition, it does not inhibit recombinant human P2Y 11 receptors. However, MRS2179 puzzlingly inhibited the fast relaxations evoked by ␣␤meATP and BzATP. Neither of these nucleotides is an agonist of P2Y 1 receptors (King and Townsend-Nicholson, 2003) ; furthermore, BzATP is an antagonist of human and rat P2Y 1 receptors (Vigne et al., 1999) . However, both ␣␤meATP and BzATP are potent agonists of P2X receptors, especially at P2X 3 and P2X 2/3 receptors (Jarvis et al., 2001 ). We looked for P2X 2 and P2X 3 protein in the taenia and found them in myenteric neurons, as have other investigators who placed these proteins alongside the enzyme nitric-oxide synthase in the majority (Ͼ80%) of inhibitory motoneurons Poole et al., 2002) . The activation of neuronal P2X 3 and P2X 2/3 receptors by ␣␤meATP and BzATP may release significant amounts of ATP (and NO) to inhibit the taenia. We have not measured ATP release and its inhibition by MRS2179. Instead, we found that the highly selective P2X 3 and P2X 2/3 receptor antagonist A317491 inhibited fast relaxations to ␣␤meATP and BzATP either when used alone or in tandem with MRS2179. Blocking P2X 3 , P2X 2/3 , and P2Y 1 receptors with A317491 and MRS2179 resulted in a new twist to this study: fast relaxations were replaced by slow relaxations. This new phenomenon seems to involve postjunctional P2Y 11 receptors.
We confirmed that both ␣␤meATP and BzATP activate human P2Y 11 receptors, resulting in calcium release from intracellular stores and increased cAMP production. ␣␤meATP has already been already shown to activate human P2Y 11 receptors expressed in human leukemic cell lines (van der Weyden et al., 2000a,b) , although this observation seems to have been overlooked. We chose the frequently used human astrocytoma 1321N1 cell line to express human P2Y 11 receptors, at which ␣␤meATP is only 2-and 4-fold less potent than ATP and BzATP, respectively. In hindsight, it seems unremarkable that ␣␤meATP is a P2Y 11 agonist, because the structurally related methylene phosphonate derivative ARC67085 is the most potent of the known P2Y 11 agonists (Abbracchio et al., 2006) . In hindsight, it is also unremarkable to link ␣␤meATP-evoked relaxations with P2Y 11 activation, because an extended series of methylene phosphonate derivatives (␤␥meATP, ␤␥Cl 2 meATP, and 2-methylthio-␤␥Cl 2 meATP), which are structurally related to the P2Y 11 agonist ARC67085 are also highly potent relaxants of the taenia (Cusack et al., 1987) . Furthermore, ␣␤meATP can directly open apamin sensitive K ϩ channels in the taenia, even in the absence of extracellular calcium, by stimulating a suramin-sensitive P2Y receptor that mobiles intracellular Ca 2ϩ stores (Den Hertog et al., 1985) . We confirmed that suramin can antagonize Ca 2ϩ responses mediated by BzATP-stimulated human P2Y 11 receptors, and we also showed that Reactive Red can do the same. In turn, Reactive Red competitively antagonized the slow relaxations evoked by BzATP in the taenia and also acted as a competitive antagonist of human P2Y 11 receptors.
We have found P2Y 11 transcripts in the taenia and also found P2Y 11 mRNA in esophagus, stomach, small intestine, and colon of human and guinea pig (our unpublished data). In humans, a short form (2-kilobase mRNA) of P2Y 11 transcripts occurs in leukocytes and spleen-derived tissue, but elsewhere mRNA exists in a series of larger chimeric forms (up to 5.6 kilobases) involving the readthrough of contiguous P2Y 11 and SSF1 genes on chromosome 19 (Abbracchio et al., 2006) . Chimeric P2Y 11 transcripts are ubiquitously distributed throughout the body, and they are abundant in brain and pituitary, but they are also present in the gastrointestinal tract (Abbracchio et al., 2006) . At present, we are unable to comment on the genomic structure and resulting tran- jpet.aspetjournals.org scription products of the guinea pig P2Y 11 receptor gene. A 187-base pair cDNA amplification product isolated from reverse transcribed RNA is homologous to the nucleotide sequences for human and canine P2Y 11 genes. However, the full gene sequence for guinea pig has eluded us, in part due to the high GC-rich content of the gene and the fact that only a low-coverage (1.92ϫ) preliminary assembly of the guinea pig genome is currently available.
EC 50 values for nucleotide-evoked slow relaxations were initially unrelated to published values for the same nucleotides activating heterologously expressed human P2Y 11 receptors (Abbracchio et al., 2006) , native P2Y 11 receptors in HL-60 cells (Conigrave et al., 1998) , or our own data on ATP, ␣␤meATP, and BzATP activation of human P2Y 11 receptors. Circumstances changed when we began to use ADA to prevent the buildup of adenosine in the taenia. Thereafter, the potency of ATP and BzATP increased significantly, and each nucleotide gave EC 50 values similar to those identified for P2Y 11 receptor activation. ADA did not exert nonspecific effects on the taenia, because it did not alter the relaxant potency of the ␤-adrenoceptor agonist isoprenaline. However, ADA did increase the potency of ␣␤meATP in the taenia, and this observation was a cause for concern, because ␣␤meATP does not readily generate adenosine. We suspect that ␣␤meATP may stimulate a subtype of neuronal P2X receptors that cannot be blocked by either MRS2179 or A317491. One possibility is the P2X 2 receptor subtype (Spelta et al., 2002) , which is present in the taenia and could be activated by the very high ␣␤meATP concentrations we used to evoke slow relaxations. In turn, the stimulation of a neuronal P2X 2 receptor population may lead to ATP release, and, ultimately, to the production of adenosine on which ADA would act. We have already shown that low concentrations of adenosine inhibit the purinergic IJP by limiting the amount of transmitter released by motoneurons in guinea pig ileum (King, 1994) .
P2Y 11 receptors can couple efficiently to both G s and G q/11 signaling proteins (Abbracchio et al., 2006) . We found that the production of cAMP (via G s stimulation), in tandem with the mobilization of intracellular Ca 2ϩ (via G q/11 stimulation), was critically important in the taenia, because the duration and amplitude of relaxations were altered by procedures that either raised or lowered intracellular cAMP levels. Cyclic AMP acts as a molecular switch for the ␣-subunit of BK Ca channels, and via subunit phosphorylation, it causes a leftward displacement of the voltage activation curve for BK Ca channels and increases the probability of channel opening (Zhou et al., 2001 ). Because of their voltage sensitivity (typically active at Ϫ40 mV or lower), BK Ca channels seem to make little or no contribution to the purinergic IJP when it is studied at the resting membrane potential of smooth muscles under investigation. However, the electrical and mechanical activities of agonist-stimulated smooth muscle are significantly potentiated by blocking BK Ca channels, which seem to subserve the regulatory role of dampening intense excitatory stimulation (Carl et al., 1995; Vogalis et al., 1996; Liu et al., 1999) . P2Y 11 -based parasympathetic inhibition may only be fully effective when smooth muscle is excited and continuously depolarized, to maximize the P2Y 11 -evoked responses of increased cAMP production and Ca 2ϩ store mobilization on BK Ca channel activation.
In summary, our study revealed that two different P2Y receptors occur on colonic SMCs and that they elicit fast or slow relaxations depending on local conditions. P2X receptors on neurons play a facilitatory role, mainly by stimulating ATP release, whereas adenosine receptors seem to do the opposite. The pharmacology of P2Y 11 receptors has been extended, further elucidating the actions of ␣␤meATP in smooth muscle. The implication of this pharmacological observation may be wide ranging, because ␣␤meATP is also capable of evoking prolonged vasorelaxation, and this action is more easily attributable to P2Y receptor activation than to P2X. 
